Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03662165 · ClinicalTrials.gov registry record · NA
Increase HIV Testing Among Truck Drivers and Female Sex Workers in Kenya Through Offering HIV Self-Testing
A NA study, sponsored by City University of New York, School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 4,458
- Enrollment target
NCT03662165: Completed NA study, sponsored by City University of New York, School of Public Health.
NCT03662165 is a NA study that has completed, run by City University of New York, School of Public Health. The registered enrollment target is 4,458 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (218% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03662165, a NA study, has completed, sponsored by City University of New York, School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,458 participants
- Enrollment target
Study Summary
The study aimed to assess whether advertising the availability of self-administered oral HIV testing kits increases the number of truck drivers and female sex workers who come to the North Star Alliance clinics for HIV testing (Demand creation). The investigators sent text messages to eligible truck drivers and female sex workers registered in the North Star Alliance electronic health record system who, based on those records, were not accessing HIV testing regularly and randomized them to receive one of two messaged, (1) the standard message sent to all clients who have not tested for HIV in the past 3 months reminding them of the availability of HIV testing at North Star clinics or (2) a text message announcing the availability of HIV self-testing kits fat all North Star clinics in Kenya. The investigators then compared the number of truck drivers and female sex workers from our samples who came to the clinic for HIV testing over a 2 month period following the first text message in the two study arms.
Primary Outcome
We compared the proportion who tested for HIV during the 2-month follow-up period among participants in the Intervention arm versus those in the Enhanced Standard of Care (SOC) arm (primary comparison) as well as among those in the Enhanced SOC versus those in the Traditional SOC arms (secondary comparison) to look at the impact of the content of the text message (i.e. about self-testing kits or HIV testing in general) and of the number of text messages (3 versus 1) on HIV testing, respectively.
Interventions
- BEHAVIORAL Intervention
- BEHAVIORAL Enhanced Standard of Care
- BEHAVIORAL Traditional Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,458 participants |
| Start Date | 2016-12-20 |
| Est. Completion | 2017-04-27 |
| Phase | NA |
What the finished NCT03662165 record still lists
NCT03662165 is an interventional study that assigns participants to a tested intervention. Its 4,458 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (218% higher).
The record links to 0 conditions, and to 3 interventions - of which Intervention is the first listed.
NCT03662165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03662165 about?
NCT03662165 is a clinical study titled "Increase HIV Testing Among Truck Drivers and Female Sex Workers in Kenya Through Offering HIV Self-Testing". The study aimed to assess whether advertising the availability of self-administered oral HIV testing kits increases the number of truck drivers and female sex workers who come to the North Star Alliance clinics for HIV testing (Demand creation). The investigators sent text messages to eligible truck...
What is the current status of trial NCT03662165?
This trial is currently completed. It is a NA study. The enrollment target is 4,458 participants. The study started on 2016-12-20. Estimated completion is 2017-04-27.
What interventions are being tested in trial NCT03662165?
The interventions under investigation include: Intervention (BEHAVIORAL), Enhanced Standard of Care (BEHAVIORAL), Traditional Standard of Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03662165?
This trial is sponsored by City University of New York, School of Public Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03662165's enrollment target sits among peer trials
4,458 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI